Autism clinical trials at UCSF
2 in progress, 1 open to eligible people
ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
open to eligible people ages 12-45
ML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and adult subjects with ASD. The primary objective is to evaluate the efficacy of ML-004 compared with placebo in the improvement of social communication deficits in subjects with ASD.
San Francisco, California and other locations
CM-AT for the Treatment of Children With Autism
Sorry, in progress, not accepting new patients
This is a Phase III, open label extension study evaluating the continued safety and efficacy of CM-AT in pediatric patients with autism with all levels of fecal chymotrypsin.
San Francisco, California and other locations
Our lead scientists for Autism research studies include Robert Hendren, DO.
Last updated: